Cargando…

PB2122: A PHASE 1/2 MULTI-CENTER, DOSE-FINDING STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PK AND EFFICACY OF ZN-D5, A NOVEL BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS

Detalles Bibliográficos
Autores principales:	Kastritis, Efstathios, Matous, Jeffrey, Berdeja, Jesus, Abro, Emad, Augustson, Bradley, Perianes, Valentin Cabañas, Cibeira, M. Theresa, Cohen, Yael, Fong, Michael, Gatt, Moshe, DE LA Calle, Veronica Gonzalez, Kwok, Fiona, Lavi, Noa, Magen, Hila, Oriol, Albert, Palladini, Giovanni, Stockerl-Goldstein, Keith, Eves, Taylor, Zheng, Cheng, Fiorino, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429019/ http://dx.doi.org/10.1097/01.HS9.0000975252.55444.26

Ejemplares similares

P914: VENETOCLAX IN RELAPSE/REFRACTORY AL AMYLOIDOSIS- A MULTICENTER INTERNATIONAL RETROSPECTIVE REAL-WORLD STUDY
por: Lebel, Eyal, et al.
Publicado: (2023)

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study
por: Lebel, Eyal, et al.
Publicado: (2023)

PX-2122 pit.
por: Jean-Luc Caron
Publicado: (1999)

PX-2122 pit.
por: Jean-Luc Caron
Publicado: (1999)

PX-2122 pit.
por: Jean-Luc Caron
Publicado: (1999)

PX-2122 pit.
por: Jean-Luc Caron
Publicado: (1999)

PX-2122 pit.
por: Jean-Luc Caron
Publicado: (1999)

PX-2122 pit.
por: Jean-Luc Caron
Publicado: (1999)

PX-2122 pit.
por: Jean-Luc Caron
Publicado: (1999)

PROJECT ADMINISTRATION AGREEMENT KN2122/EN
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2013)

Installing the work platform of the PX-2122 pit at LHC Point 1
por: Jean-Luc Caron
Publicado: (1998)

2122: Factors associated with unintended pregnancy in cancer survivors after cancer
por: Shandley, Lisa M., et al.
Publicado: (2018)

2122. Isavuconazonium for Invasive Fungal Therapy: Single-Center Pediatric Experience
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

Updated Reference Genome Sequence and Annotation of Mycobacterium bovis AF2122/97
por: Malone, Kerri M., et al.
Publicado: (2017)

Updated functional annotation of the Mycobacterium bovis AF2122/97 reference genome
por: Farrell, Damien, et al.
Publicado: (2020)

Sars-Cov-2 Infection and Systemic Light Chain Amyloidosis: The International Society of Amyloidosis' Survey
por: Milani, Paolo, et al.
Publicado: (2020)

Novel miR-b2122 regulates several ALS-related RNA-binding proteins
por: Hawley, Zachary C. E., et al.
Publicado: (2017)

PB2122: THE EFFICACY OF THE STANDARD AND INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH DOUBLE- AND TRIPLE-EXPRESSOR LYMPHOMA.
por: Fujita, M., et al.
Publicado: (2022)

Evidence for narrow dibaryons at 2050, 2122 and 2150 MeV observed in inelastic p p scattering
por: Tatischeff, B, et al.
Publicado: (1999)

PReS-FINAL-2122: Autologous stem cell transplantation in a patient with severe systemic sclerosis in Portugal
por: Guedes, M, et al.
Publicado: (2013)

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
por: Shragai, Tamir, et al.
Publicado: (2022)

The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expression
por: Gilad, Nechama, et al.
Publicado: (2019)

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p
por: Wong, Sandy W., et al.
Publicado: (2018)

2122 Perspectives on increasing competency in using digital practices and approaches to enhance clinical translational research: A qualitative study
por: Reuter, Katja, et al.
Publicado: (2018)

2122. In Vitro Activity of Cefepime-Taniborbactam Against Clinically Significant Gram-Negative Bacteria Isolated from Patients with Cancer
por: Gerges, Bahgat Z, et al.
Publicado: (2023)

Diagnostic Challenges and Solutions in Systemic Amyloidosis
por: Goldis, Rivka, et al.
Publicado: (2023)

How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis
por: Rubinstein, Samuel M., et al.
Publicado: (2021)

COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury
por: Crees, Zachary D., et al.
Publicado: (2022)

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
por: Srinivasan, Krithia, et al.
Publicado: (2022)

The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018
por: Palladini, Giovanni, et al.
Publicado: (2023)

P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE
por: Jaccard, A., et al.
Publicado: (2022)

Corrigendum to “Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer”
por: Harpaz, Noa, et al.
Publicado: (2020)

Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer
por: Harpaz, Noa, et al.
Publicado: (2020)

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
por: Zhang, Kathleen W., et al.
Publicado: (2019)

Characterization of prickle isoform-specific pk (pk1) and pk (sple1) mutations in Drosophila melanogaster
por: Lilienthal, Anthony J, et al.
Publicado: (2022)

2122. Can Chlorhexidine Reduce Bacterial Colonization in Surgical Drains and Surgical Site Infections After Breast Cancer Surgery? A Randomized Controlled Trial
por: Rivera-Buendía, Frida, et al.
Publicado: (2018)

Pure red cell aplasia in a simultaneous pancreas-kidney transplantation patient: inside the erythroblast
por: Labbadia, Francesca, et al.
Publicado: (2012)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

AL AMYLOIDOSIS: MECHANISMS OF DISEASE AND BIOMARKERS
por: Palladini, Giovanni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6dns7uk0lmnbem807rkav0hkek